Pinnow Cole has filed 7 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 50000 shares of Cogent Biosciences, Inc. ($COGT) on December 17, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | A | Common Stock | 50000 | $0.00 | 97,450.0000 | 142,376,529 | 105.37% | 0.04% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | A | Common Stock | 214000 | $0.00 | 311,450.0000 | 142,376,529 | 219.60% | 0.15% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | F | Common Stock | 94800 | $39.45 | 216,650.0000 | 142,376,529 | 30.44% | 0.07% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 142,376,529 | 9999.99% | 0.05% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 14, 2025 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | P | Common Stock | 43750 | $7.60 | 45,848.0000 | 0 | 2085.32% | 0.00% |
| May 25, 2024 | Cogent Biosciences, Inc. | $COGT | Pinnow Cole | Chief Commercial Officer | A | Stock Option (Right to Buy) | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |